A retrospective analysis analyzing 450 HER2-positive breast cancer patients showed that HR-negative subtype was associated with an inferior prognosis [9], while some studies indicated no significant difference existing in the long-term survival of patients between the two subgroups [10–12]. The gene discussed is ERBB2; the disease is breast cancer.